6896.HKHKSE
Golden Throat Holdings Group Company Limited
HK$3.09
ListedJul 15, 2015
SectorHealthcare
IndustryDrug Manufacturers — Specialty & Generic
CountryChina
Employees840
State-| CityLiuzhou| AddressNo. 28 Fengxiang Road| Phone86 77 2282 5718
Golden Throat Holdings Group Company Limited, an investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People's Republic of China and internationally. The company offers Golden Throat Lozenges, an over-the-counter medicine to relieve symptoms of sore and dry throat, and hoarse voice caused by acute pharyngitis. It also provides Golden Throat Lozenge series products, which include Dule Lozenges; sugar-free Dule Lozenges; and other sugar free flavors, such as orange, fructus momordicae, chrysanthemum, American ginseng, and hawthorn. In addition, the company offers Yinxingye tablets to facilitate blood circulation, remove blood stasis, and dredge energy channels; Golden Throat Propolis Soothing Spray Series; Golden Throat intestinal series for probiotics; and Golden Throat Compound Probiotic Lozenges. It exports its products to approximately 60 countries and regions. Golden Throat Holdings Gro3WEup Company Limited was founded in 1956 and is headquartered in Liuzhou, the People's Republic of China.

Key Indicators

Key financial and dividend metrics for this stock.

?
P/E Ratio
8.7
?
Div. Rate
HK$0.34
?
Div. Yield
10.03%
?
Payout Ratio
134.46%
?
Max Consec. Div. Years
10 years
?
Longest Consec. Div.
10 years
?
Div. Coverage
100%
?
Div. Stability Rate
0.65
?
Div. Growth Rate
75.00%
?
Score
75

Dividend History

Historical dividend payments by ex-dividend date.

Jun 16, 2025
HK$ 0.5000
Jun 14, 2024
HK$ 0.6000
Jun 16, 2023
HK$ 0.3600
May 25, 2022
HK$ 0.1800
Jun 16, 2021
HK$ 0.0600
Jun 8, 2020
HK$ 0.1200
May 23, 2019
HK$ 0.1200
May 21, 2018
HK$ 0.0600
Dec 13, 2017
HK$ 0.0600
Jun 12, 2017
HK$ 0.0600
Jan 9, 2017
HK$ 0.0600
May 26, 2016
HK$ 0.0600

Peer Companies

Other stocks in the same sector.

The app download will be available in the next version. Stay tuned!